Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

EGFR mutations and tumor metastases in patients with nonsmall cell lung cancer in the South of Russia.

Autor: Kit OI; Rostov Research Institute of Oncology, Rostov-on-Don, Russia., Vodolazhsky DI, Timoshkina NN, Vladimirova LY, Turkin IN, Kutsyn KA, Enin YS, Panina SB, Jurisic V

Publikováno v: Journal of B.U.ON. : official journal of the Balkan Union of Oncology [J BUON] 2017 Nov-Dec; Vol. 22 (6), pp. 1410-1415.

[The role of assessing UGT1A1 gene polymorphism in the prediction of irinotecan-induced toxicity in the course of chemotherapy for colorectal cancer].

Autor: Kit OI, Vladimirova LY, Vodolazhskiy DI, Abramova NA, Dvadnenko KV

Publikováno v: Voprosy onkologii [Vopr Onkol] 2015; Vol. 61 (2), pp. 266-9.

Characteristics of Patients with Pleural Mesothelioma in the Russian Federation.

Autor: Gorbounova VA; N. N. Blokhin Russian Cancer Research Center, Moscow, Russia., Bychkov MB; N. N. Blokhin Russian Cancer Research Center, Moscow, Russia., Vladimirova LY; Rostov Scientific Research Oncological Institute, Rostov-on-Don, Russia., Levchenko EV; N. N. Petrov Research Oncology Institute, Saint-Petersburg, Russia., Karpenko TD; N. N. Blokhin Russian Cancer Research Center, Moscow, Russia., Mamontov OY; N. N. Petrov Research Oncology Institute, Saint-Petersburg, Russia., Burmistrov V; Eli Lilly Vostok S. A., Moscow, Russia., Novick D; Eli Lilly Holdings Limited, Windlesham, UK., Rajan N; Eli Lilly Australia Pty Ltd, West Ryde, NSW, Australia., Sholokhova E; Eli Lilly Vostok S. A., Moscow, Russia., Solovyenko Y; Eli Lilly Vostok S. A., Moscow, Russia., Tjulandin SA; N. N. Blokhin Russian Cancer Research Center, Moscow, Russia.

Publikováno v: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2014 Nov; Vol. 17 (7), pp. A617. Date of Electronic Publication: 2014 Oct 26.